Small Molecule May Inhibit Malignancies in Stem Cell-Derived Therapies

Date:

Los Angeles/Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Jonsson Comprehensive Cancer Center – Scientists at UCLA have identified MitoBloCK-6 as a small molecule that may prevent unintended cells from developing into malignancies during stem cell therapies.

Go Back

Top

Login

Lost your password?